Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linagliptin versus glimepiride on renal physiology in metformin-treated type 2 diabetes
NL-OMON41714Phase 4Active, not recruiting
- Sponsor
- Vrije University Medical Center
- Start
- May 2014
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Linagliptin with Glimepiride (2 arms). Primary endpoints: Change in glomerular filtration rate and Change in effective renal plasma flow. Started May 2014; status: active, not recruiting.
02
Drugs
linagliptinglimepiride
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NL-OMON41714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41714.